Literature DB >> 22340923

Patient education program for venous thromboembolism prevention in hospitalized patients.

Gregory Piazza1, Thanh Nha Nguyen, Ruth Morrison, Deborah Cios, Benjamin Hohlfelder, John Fanikos, Marilyn D Paterno, Samuel Z Goldhaber.   

Abstract

PURPOSE: Up to 15% of clinician-ordered doses of injectable pharmacological prophylaxis to prevent venous thromboembolism are not administered. Patient refusal accounts for nearly 50% of these omitted doses. We conducted a prospective cohort study to determine whether a patient education program would improve medication adherence to clinician-ordered injectable prophylactic anticoagulation.
METHODS: We identified 528 hospitalized patients ordered to receive injectable pharmacological venous thromboembolism prophylaxis. We evaluated the impact of pharmacist-led patient education sessions on medication adherence (defined as the ratio of doses administered to doses scheduled) compared with our historical cohort.
RESULTS: Individualized patient education sessions were conducted within 24 hours of the initial order for prophylactic anticoagulation in 99% of patients. Adherence to clinician-ordered pharmacological venous thromboembolism prophylaxis was higher after the patient education program than in our historical cohort (94.4% vs 89.9%, P <.0001). The proportion of patients receiving 100% of scheduled doses of injectable pharmacological venous thromboembolism prophylaxis was higher after our novel patient education program than in our historical cohort (73.7% vs 62.4%, P=.001). Patient refusal as a reason for omitted doses was less frequent after the patient education program (29.3% vs 43.7%, P=.001).
CONCLUSION: Pharmacist-led individualized patient education sessions were associated with higher medication adherence to clinician-ordered injectable pharmacological venous thromboembolism prophylaxis and a reduction in patient refusal as a reason for omitted doses. A randomized controlled trial to evaluate the impact of a patient education program on medication adherence to pharmacological venous thromboembolism prophylaxis is warranted. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340923     DOI: 10.1016/j.amjmed.2011.09.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  What the 2018 ASH venous thromboembolism guidelines omitted: nonadministration of pharmacologic prophylaxis in hospitalized patients.

Authors:  Oluwafemi P Owodunni; Brandyn D Lau; Michael B Streiff; Peggy S Kraus; Deborah B Hobson; Dauryne L Shaffer; Kristen L W Webster; Mujan Varasteh Kia; Christine G Holzmueller; Elliott R Haut
Journal:  Blood Adv       Date:  2019-02-26

Review 2.  Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies.

Authors:  Kenneth M Shermock; Brandyn D Lau; Elliott R Haut; Deborah B Hobson; Valerie S Ganetsky; Peggy S Kraus; Leigh E Efird; Christoph U Lehmann; Brian L Pinto; Patricia A Ross; Michael B Streiff
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

3.  Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis.

Authors:  Anthony D Yang; Daniel Brock Hewitt; Eddie Blay; Lindsey J Kreutzer; Christopher M Quinn; Kimberly A Cradock; Vivek Prachand; Karl Y Bilimoria
Journal:  Ann Surg       Date:  2020-06       Impact factor: 13.787

4.  Strategies for improving the quality of verbal patient and family education: a review of the literature and creation of the EDUCATE model.

Authors:  Cara Marcus
Journal:  Health Psychol Behav Med       Date:  2014-04-28

5.  Patients' perceptions and experiences of the prevention of hospital-acquired thrombosis: a qualitative study.

Authors:  Patricia N Apenteng; David Fitzmaurice; Ian Litchfield; Sian Harrison; Carl Heneghan; Alison Ward; Sheila Greenfield
Journal:  BMJ Open       Date:  2016-12-13       Impact factor: 2.692

6.  Effectiveness of two distinct web-based education tools for bedside nurses on medication administration practice for venous thromboembolism prevention: A randomized clinical trial.

Authors:  Brandyn D Lau; Dauryne L Shaffer; Deborah B Hobson; Gayane Yenokyan; Jiangxia Wang; Elizabeth A Sugar; Joseph K Canner; David Bongiovanni; Peggy S Kraus; Victor O Popoola; Hasan M Shihab; Norma E Farrow; Jonathan K Aboagye; Peter J Pronovost; Michael B Streiff; Elliott R Haut
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

7.  Developing an Economic Case of Clinical Pharmacists' Interventions on Venous Thromboembolism Prophylaxis Through Service Evaluation.

Authors:  Eun Hee Lee; Victoria Bray; Robert Horne
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

Review 8.  Practices to prevent venous thromboembolism: a brief review.

Authors:  Brandyn D Lau; Elliott R Haut
Journal:  BMJ Qual Saf       Date:  2013-05-24       Impact factor: 7.035

Review 9.  Principles and theory guiding development and delivery of patient education in disorders of thrombosis and hemostasis: Reviewing the current literature.

Authors:  Julia Hews-Girard; Christine Guelcher; Jennifer Meldau; Ellen McDonald; Fiona Newall
Journal:  Res Pract Thromb Haemost       Date:  2017-09-20

10.  Effect of Real-time Patient-Centered Education Bundle on Administration of Venous Thromboembolism Prevention in Hospitalized Patients.

Authors:  Elliott R Haut; Jonathan K Aboagye; Dauryne L Shaffer; Jiangxia Wang; Deborah B Hobson; Gayane Yenokyan; Elizabeth A Sugar; Peggy S Kraus; Norma E Farrow; Joseph K Canner; Oluwafemi P Owodunni; Katherine L Florecki; Kristen L W Webster; Christine G Holzmueller; Peter J Pronovost; Michael B Streiff; Brandyn D Lau
Journal:  JAMA Netw Open       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.